Science ❯Pharmacology

Drug Development

Clinical Trials Clinical Studies Clinical Research Weight Loss Drugs Clinical Applications Therapeutic Effects Clinical Testing Smoking Cessation Aids Sildenafil L-Dopa Drug Design

Novel Non-Opioid Analgesic ADRIANA Advances to U.S. Phase II Trials

The α2B-adrenoceptor blocker moves into large-scale U.S. Phase II testing after early Japanese trials showed it to be safe with maintained efficacy.

102-Year-Old Becomes Oldest NHS Viagra Recipient as Prescriptions Reach Record Levels

UK to Trial Pharmacy-Based NHS Weight-Loss Jab Prescriptions

Widespread Use of Weight-Loss Drugs Redefines Health, Beauty, and Access

NHS Rolls Out Varenicline to Help Smokers Quit

Limited Access to Popular Weight-Loss Drugs Highlights Socioeconomic Disparities

Cost and Efficacy Concerns Arise for GLP-1 Weight Loss Drugs

Eli Lilly Fights Back Against Compounded Tirzepatide Amid FDA Supply Resolution

Weight Loss Drug Liraglutide Shows Promise for Children as Young as Six